Ligand Pharmaceuticals (LGND) Times Interest Earned (2010 - 2026)

Ligand Pharmaceuticals has disclosed Times Interest Earned across 17 years of filings, most recently posting $9.94 for Q1 2026.

• Times Interest Earned for Q1 2026 came in at $9.94, up 123.8% year-over-year; the trailing twelve-month figure through Mar 2026 was $16.91 (up 202.81% YoY), and the FY2025 annual result was $8.7, up 216.83% from the prior year.
• Times Interest Earned came in at $9.94 for Q1 2026 at Ligand Pharmaceuticals, up from $7.76 in the prior quarter.
• In the past five years, Times Interest Earned ranged from a high of $3078.0 in Q3 2023 to a low of -$83.75 in Q4 2022.
• The 5-year median for Times Interest Earned is $7.32 (2025), against an average of $183.74.
• Across the five-year window, Times Interest Earned plunged 1092.11% in 2022 and soared 8180.5% in 2023, its largest moves.
• Ligand Pharmaceuticals' Times Interest Earned stood at -$83.75 in 2022, then surged by 69.39% to -$25.63 in 2023, then surged by 57.42% to -$10.91 in 2024, then soared by 171.06% to $7.76 in 2025, then increased by 28.19% to $9.94 in 2026.
• The last three Times Interest Earned figures came in at $9.94 (Q1 2026), $7.76 (Q4 2025), and $60.36 (Q3 2025), per Business Quant data.